Stock of Interest

Posted On: August 9, 2023

Stock Report: CAPLIPOINT (NSE) 08 Aug 2023

Caplin Point Laboratories Limited (NSE: CAPLIPOINT) is a pharmaceutical company based in Chennai, India. It was founded in 1990 and is engaged in the manufacturing and marketing of a wide range of pharmaceutical products. The company primarily focuses on the development and production of generic and branded pharmaceutical formulations, including injectables, ointments, creams, and oral dosage forms. As of 2022, Caplin Point Laboratories had approximately 3,000 employees. The company operates through various subsidiaries, including Caplin Steriles Limited and Argus Salud Pharma LLP. These subsidiaries likely contribute to the company’s overall operations, allowing it to expand its product portfolio and reach in the pharmaceutical market.

#xCalData predicts that #CAPLIPOINT will continue its bearish phase over the next five days and trend within the range of 1051 to 909.  

In comparison to the previous month, the price of the stock has experienced a increase of 26.63% indicating a bullish.   

The Stock has doubled thrice since 06 Jan 2015 and took an average of 0.8 years to double.   

The stock has not shown seasonality trend in the past. 

Reviewing the returns for the past 5 years for the same week, we see the stock has given positive returns in 3 years in the past. 

Majority of the technical ratios trend towards Bullish side of the spectrum. 

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData